Opportunity Information: Apply for RFA DA 28 011
The HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) funding opportunity (RFA-DA-28-011) is a National Institutes of Health (NIH) grant program that aims to renew and expand the IMPOWR research network. This network is designed to generate practical, evidence-based solutions for a high-need population: people living with both chronic pain (CP) and opioid use disorder (OUD). A key emphasis of the opportunity is not only testing better clinical approaches, but also ensuring those approaches translate into meaningful improvements in how health systems organize and deliver integrated care for these co-occurring conditions.
The renewed IMPOWR network will be structured as multiple individual research centers or projects that operate as part of a coordinated, multi-site program. These research centers will be supported by a central Coordination Center, which is intended to help align protocols, measures, operational processes, and cross-site collaboration so the network functions as a unified effort rather than disconnected studies. Because the activity code is RM1 and the solicitation notes "Clinical Trial Required," applicants should expect that the funded research will include clinical trials as a core component, meaning the work must involve prospective assignment to an intervention and the evaluation of health-related outcomes.
The scientific and practical goal is to test new or improved interventions, care models, or service delivery strategies that address chronic pain and OUD together, with an eye toward "whole recovery." In practice, this usually implies approaches that move beyond treating pain and addiction in separate silos and instead integrate pain management, OUD treatment, behavioral health supports, and recovery-oriented services in ways that patients can realistically access and sustain. The opportunity also signals a strong implementation and health systems orientation: the end product should be approaches that can be adopted by real-world health systems and that improve care delivery, not just demonstrate efficacy under ideal conditions.
This program sits under the broader NIH Helping to End Addiction Long-term (HEAL) Initiative, a major federal research effort focused on accelerating solutions to the opioid crisis. HEAL has two central research thrusts reflected here: improving prevention and treatment of opioid misuse and OUD, and enhancing pain management. IMPOWR specifically targets the intersection of these challenges, where pain can complicate addiction treatment and OUD can complicate pain care, creating a cycle that health systems often struggle to address effectively.
In terms of applicant eligibility, the opportunity is broadly open across many organization types. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (including those other than small businesses); and small businesses. Additional eligible applicant categories explicitly noted include Indian/Native American Tribal Governments other than federally recognized, eligible federal agencies, U.S. territories or possessions, faith-based or community-based organizations, regional organizations, and even non-U.S. (foreign) institutions. That breadth suggests NIH is aiming to attract multidisciplinary teams and a variety of settings, including community-based and system-level partners capable of conducting clinical trials and implementing integrated care models.
Administratively, this is a discretionary grant opportunity in the health category, administered by NIH. The CFDA (Assistance Listing) numbers associated with the opportunity include 93.213, 93.273, 93.279, 93.853, and 93.866, reflecting NIH’s multi-institute participation typical of HEAL network efforts. The posted original closing date is January 26, 2027, and the opportunity was created on October 6, 2026. An award ceiling and expected number of awards are not listed in the provided source details, which generally means applicants should rely on the full funding announcement and NIH guidance for budget and award expectations.
Overall, IMPOWR Research Centers funding is aimed at building a coordinated, clinically rigorous, and implementation-relevant research network that can test and refine integrated strategies for chronic pain and OUD, generate actionable evidence for health systems, and contribute directly to HEAL’s national mission of improving pain care while reducing opioid-related harms.Apply for RFA DA 28 011
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.273, 93.279, 93.853, 93.866.
- This funding opportunity was created on 2026-10-06.
- Applicants must submit their applications by 2027-01-26.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): IMPOWR Research Centers (RFA-DA-28-011)
What is the IMPOWR Research Centers funding opportunity (RFA-DA-28-011)?
This opportunity is an NIH grant program under the HEAL Initiative titled "The HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required)." It aims to renew and expand the IMPOWR research network to develop practical, evidence-based solutions for people living with both chronic pain (CP) and opioid use disorder (OUD).
What is the overall purpose of the renewed IMPOWR network?
The purpose is to create a coordinated, multi-site research network that tests new or improved interventions, care models, or service delivery strategies addressing chronic pain and OUD together, with a strong focus on approaches that can be adopted in real-world health systems and improve how integrated care is delivered.
Who is the target population for this research?
The network is focused on a high-need population: people who have both chronic pain (CP) and opioid use disorder (OUD). The research is intended to support "whole recovery" by addressing these co-occurring conditions in an integrated way.
What does "whole recovery" mean in the context of this opportunity?
Based on the description provided, "whole recovery" generally points to care approaches that do not treat pain and addiction in separate silos. Instead, it implies integrated strategies that combine pain management, OUD treatment, behavioral health supports, and recovery-oriented services in ways patients can realistically access and sustain.
What NIH activity code is used, and what does it imply?
The activity code is RM1. The solicitation also states "Clinical Trial Required," indicating that clinical trials are expected to be a core component of the funded research centers or projects.
Is a clinical trial required?
Yes. The opportunity explicitly indicates "Clinical Trial Required." This means the work should include clinical trials, described here as involving prospective assignment to an intervention and evaluation of health-related outcomes.
What kinds of projects are expected to be funded through IMPOWR Research Centers?
The program is intended to support research that tests new or improved interventions, care models, or service delivery strategies that address chronic pain and OUD together. It places strong emphasis on implementation and health system relevance, with the goal of producing approaches that can be adopted by real-world health systems to improve integrated care delivery.
How is the IMPOWR network organized?
The renewed network will consist of multiple individual research centers or projects that operate as part of a coordinated, multi-site program. These sites are supported by a central Coordination Center intended to align protocols, measures, operational processes, and cross-site collaboration so the network functions as a unified effort rather than separate, disconnected studies.
What is the role of the Coordination Center?
The Coordination Center is intended to support network-wide alignment by helping standardize or coordinate protocols, measures, operational processes, and collaboration across sites. The goal is to enable cross-site cohesion and unified execution across the network.
What is meant by an "implementation and health systems orientation"?
The opportunity highlights that the end product should be more than evidence of efficacy under ideal research conditions. It should produce approaches that can realistically be adopted by health systems and that improve care delivery for patients with co-occurring chronic pain and OUD.
How does this opportunity connect to the HEAL Initiative?
IMPOWR is part of the broader NIH Helping to End Addiction Long-term (HEAL) Initiative, a federal research effort focused on accelerating solutions to the opioid crisis. HEAL emphasizes both improving prevention/treatment of opioid misuse and OUD and enhancing pain management; IMPOWR targets the intersection of chronic pain and OUD.
Why focus specifically on the intersection of chronic pain and OUD?
The description notes that chronic pain can complicate addiction treatment and OUD can complicate pain care, potentially creating a cycle that health systems struggle to address effectively. IMPOWR is intended to develop integrated strategies that address both conditions together.
Who is eligible to apply for this funding opportunity?
Eligibility is broadly open to many organization types, including: state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits (with or without 501(c)(3) status, other than institutions of higher education); for-profit organizations (including those other than small businesses); and small businesses. Additional eligible categories explicitly noted include Indian/Native American Tribal Governments other than federally recognized, eligible federal agencies, U.S. territories or possessions, faith-based or community-based organizations, regional organizations, and non-U.S. (foreign) institutions.
Can for-profit organizations and small businesses apply?
Yes. The eligibility list includes for-profit organizations (including those other than small businesses) and also includes small businesses.
Can nonprofits apply even if they do not have 501(c)(3) status?
Yes. Eligible applicants include nonprofits with or without 501(c)(3) status (other than institutions of higher education).
Are non-U.S. (foreign) institutions eligible to apply?
Yes. The provided eligibility information explicitly includes non-U.S. (foreign) institutions among eligible applicants.
Are tribal governments and tribal organizations eligible?
Yes. Eligibility includes federally recognized Native American tribal governments and tribal organizations other than federally recognized tribal governments. The opportunity also explicitly notes Indian/Native American Tribal Governments other than federally recognized as eligible.
Which federal agency administers this grant opportunity?
The opportunity is administered by the National Institutes of Health (NIH) as a discretionary grant program in the health category.
What are the Assistance Listing (CFDA) numbers associated with this opportunity?
The CFDA (Assistance Listing) numbers associated with this opportunity include 93.213, 93.273, 93.279, 93.853, and 93.866.
When was this opportunity created, and what is the original closing date?
The opportunity was created on October 6, 2026. The posted original closing date is January 26, 2027.
Is the award ceiling provided? Is the expected number of awards listed?
No. The provided details indicate that an award ceiling and the expected number of awards are not listed in the source information. Applicants are expected to rely on the full funding announcement and NIH guidance for budget and award expectations.
What makes this a network-focused opportunity rather than standalone studies?
The opportunity is structured around multiple research centers/projects operating as part of a coordinated, multi-site program, supported by a Coordination Center to align measures, protocols, operations, and collaboration. This design is meant to produce a unified network rather than isolated studies.
What is the main practical outcome NIH appears to be seeking through IMPOWR?
The description emphasizes actionable, real-world improvements in how health systems organize and deliver integrated care for chronic pain and OUD. The intent is to generate practical, evidence-based solutions that can translate into meaningful changes in care delivery.
Browse more opportunities from the same category: Health
Previous opportunity: Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 28 011
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 28 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) Apply for RFA DA 28 012 Funding Number: RFA DA 28 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) Apply for RFA NS 28 010 Funding Number: RFA NS 28 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) Apply for PAR 28 022 Funding Number: PAR 28 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) Apply for RFA DA 28 013 Funding Number: RFA DA 28 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) Apply for RFA DK 27 122 Funding Number: RFA DK 27 122 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) Apply for PAR 27 090 Funding Number: PAR 27 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) Apply for PAR 28 090 Funding Number: PAR 28 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) Apply for RFA AI 27 018 Funding Number: RFA AI 27 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) Apply for RFA CA 28 013 Funding Number: RFA CA 28 013 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) Apply for RFA AI 28 031 Funding Number: RFA AI 28 031 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) Apply for RFA CA 28 004 Funding Number: RFA CA 28 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 28 001 Funding Number: RFA AA 28 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,150,000 |
| NIH Research Program Projects (Parent P01 Clinical Trial Optional) Apply for PA 27 061 Funding Number: PA 27 061 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) Apply for PAR 27 045 Funding Number: PAR 27 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) Apply for RFA LM 28 001 Funding Number: RFA LM 28 001 Agency: National Institutes of Health Category: Health Funding Amount: $775,000 |
| Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) Apply for PAR 27 003 Funding Number: PAR 27 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) Apply for RFA RM 27 024 Funding Number: RFA RM 27 024 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) Apply for PAR 28 014 Funding Number: PAR 28 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) Apply for RFA RM 27 025 Funding Number: RFA RM 27 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 28 024 Funding Number: RFA AI 28 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 28 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
